Browsing by Author "Ingenrieth F."

Now showing 1 - 2 of 2
  • No Thumbnail Available
    Item
    Geolocation with respect to personal privacy for the Allergy Diary app - A MASK study
    (BioMed Central Ltd., 2018) Bousquet J.; Agache I.; Almeida R.; Angles R.; Annesi-Maesano I.; Anto J.M.; Arnavielhe S.; Asayag E.; Bacci E.; Bachert C.; Baiardini I.; Baroni I.; Barreto B.A.; Basagana X.; Bedbrook A.; Bedolla-Barajas M.; Bergmann K.C.; Bertorello L.; Bewick M.; Bialek S.; Bieber T.; Bindslev-Jensen C.; Bjermer L.; Blua A.; Marciniak M.B.; Bogus-Buczynska I.; Bosnic-Anticevich S.; Bosse I.; Bouchard J.; Bourret R.; Briedis V.; Bucca C.; Buonaiuto R.; Cabanas M.T.B.; Caiazza D.; Caillot D.; Caimmi D.; Camargos P.; Canfora G.; Cardona V.; Carriazo A.M.; Cartier C.; Coelho A.C.C.; Castellano G.; Cecchi L.; Chavannes N.H.; Ciaravolo M.M.; Cingi C.; Ciceran A.; Colas L.; Colgan E.; Coll J.; Conforti D.; Sousa J.C.D.; Cortés-Grimaldo R.M.; Corti F.; Costa D.J.; Dominguez M.C.C.; Courbis A.L.; Cruz A.A.; Custovic A.; Czarlewski W.; Dario C.; Silva J.D.; Dauvilliers Y.; Carlo G.D.; Blay F.D.; Dedeu T.; Emerson M.F.; Feo G.D.; Cruz M.H.G.; Martino B.D.; Demoly P.; Rubini N.P.M.; Devillier P.; De Vries G.; Ercolano S.D.C.; Di Carluccio N.; Dray G.; Dubakiene R.; Eller E.; Emuzyte R.; Espinoza-Contreras J.M.; Estrada-Cardona A.; Farrell J.; Farsi A.; de Mello J.F., Jr.; Ferrero J.; Fokkens W.J.; Fonseca J.; Fontaine J.F.; Forti S.; Garcia-Aymerich J.; Gálvez-Romero J.L.; García-Cobas C.I.; Gemicioğlu B.; van Wijk R.G.; Guidacci M.; Gómez-Vera J.; Guldemond N.A.; Gutter Z.; Haahtela T.; Hajjam J.; Hellings P.W.; Hernández L.; Illario M.; Ivancevich J.C.; Jares E.; Joos G.; Just J.; Kalayci O.; Kalyoncu A.F.; Karjalainen J.; Keil T.; Khaltaev N.; Klimek L.; Kowalski M.L.; Kull I.; Kuna P.; Kvedariene V.; Kolek V.; Krzych-Fałta E.; Kupczyk M.; Lacwik P.; Larenas-Linnemann D.; Laune D.; Lauri D.; Lavrut J.; Lessa M.A.; Levato G.; Lewis L.; Lieten I.; Lipiec A.; Louis R.; Luna-Pech J.A.; Maciej K.; Magnan A.; Malva J.; Maspero J.F.; Mathieu-Dupas E.; Matos A.L.; Mayora O.; Medina-ávalos M.A.; Melen E.; Menditto E.; Millot-Keurinck J.; Mizani M.A.; Moda G.; Morais-Almeida M.; Morato-Castro F.F.; Santo P.M.; Mösges R.; Mota-Pinto A.; Mullol J.; Murraro A.; Murray R.; Nalin M.; Noguès M.; Novellino E.; Napoli L.; Neffen H.; O’hehir R.E.; Onorato G.L.; Palkonen S.; Papadopoulos N.G.; Passalacqua G.; Pépin J.L.; Pereira A.M.; Persico M.; Pfaar O.; Picard R.; Poncelet P.; Portejoie F.; Pozzi A.C.; Price D.; Prokopakis E.P.; Puy R.; Pugin B.; Przemecka-Green M.; Raciborski F.; Rajabian-Soderlund R.; Reitsma S.; Ribeirinho I.; Rimmer J.; Rizzo J.A.; Rizzo M.C.; Robalo-Cordeiro C.; Rodo X.; Valle S.R.; Rodríguez-González M.; Rolla G.; Roller-Wirnsberger R.E.; Romano A.; Romano M.; Rosario N.; Ryan D.; Salimäki J.; Samolinski B.; Samreth D.; Shamai S.; Sheikh A.; Sierra M.; Simons F.E.R.; Solé D.; Sorlini M.; Spranger O.; Stellato C.; Stelmach A.R.; Strozek J.; Stukas R.; Sutherland M.; Szylling A.; Tebyriçá J.N.; Thibaudon M.; Tibaldi V.; Todo-Bom A.; Toppila-Salmi S.; Tomazic P.; Trama U.; Triggiani M.; Urrutia-Pereira M.; Valero A.; Valovirta E.; Valiulis A.; Vandenplas O.; van Eerd M.; Vasankari T.; Vatrella A.; Ventura M.T.; Verissimo M.T.; Viart F.; Williams S.; Wagenmann M.; Westman M.; Wickman M.; Wroczynski P.; Yorgancioglu A.; Zernotti E.; Zurbierber T.; Zubrinich C.; Zurkuhlen A.; Ingenrieth F.; Costa E.; Fuentes-Pérez J.-M.; Huerta-Villalobos Y.R.; da Silva J.; Makris M.; Psarros F.; Sova M.; Wehner K.; Wittmann J.
    Background: Collecting data on the localization of users is a key issue for the MASK (Mobile Airways Sentinel networK: the Allergy Diary) App. Data anonymization is a method of sanitization for privacy. The European Commission's Article 29 Working Party stated that geolocation information is personal data. To assess geolocation using the MASK method and to compare two anonymization methods in the MASK database to find an optimal privacy method. Methods: Geolocation was studied for all people who used the Allergy Diary App from December 2015 to November 2017 and who reported medical outcomes. Two different anonymization methods have been evaluated: Noise addition (randomization) and k-anonymity (generalization). Results: Ninety-three thousand one hundred and sixteen days of VAS were collected from 8535 users and 54,500 (58.5%) were geolocalized, corresponding to 5428 users. Noise addition was found to be less accurate than k-anonymity using MASK data to protect the users' life privacy. Discussion: k-anonymity is an acceptable method for the anonymization of MASK data and results can be used for other databases. © 2018 The Author(s).
  • No Thumbnail Available
    Item
    Prioritizing research challenges and funding for allergy and asthma and the need for translational research—The European Strategic Forum on Allergic Diseases
    (Blackwell Publishing Ltd, 2019) Agache I.; Annesi-Maesano I.; Bonertz A.; Branca F.; Cant A.; Fras Z.; Ingenrieth F.; Namazova-Baranova L.; Odemyr M.; Spanevello A.; Vieths S.; Yorgancioglu A.; Alvaro-Lozano M.; Barber Hernandez D.; Chivato T.; Del Giacco S.; Diamant Z.; Eguiluz-Gracia I.; van Wijk R.G.; Gevaert P.; Graessel A.; Hellings P.; Hoffmann-Sommergruber K.; Jutel M.; Lau S.; Lauerma A.; Maria Olaguibel J.; O'Mahony L.; Ozdemir C.; Palomares O.; Pfaar O.; Sastre J.; Scadding G.; Schmidt-Weber C.; Schmid-Grendelmeier P.; Shamji M.; Skypala I.; Spinola M.; Spranger O.; Torres M.; Vereda A.; Bonini S.
    The European Academy of Allergy and Clinical Immunology (EAACI) organized the first European Strategic Forum on Allergic Diseases and Asthma. The main aim was to bring together all relevant stakeholders and decision-makers in the field of allergy, asthma and clinical Immunology around an open debate on contemporary challenges and potential solutions for the next decade. The Strategic Forum was an upscaling of the EAACI White Paper aiming to integrate the Academy's output with the perspective offered by EAACI's partners. This collaboration is fundamental for adapting and integrating allergy and asthma care into the context of real-world problems. The Strategic Forum on Allergic Diseases brought together all partners who have the drive and the influence to make positive change: national and international societies, patients’ organizations, regulatory bodies and industry representatives. An open debate with a special focus on drug development and biomedical engineering, big data and information technology and allergic diseases and asthma in the context of environmental health concluded that connecting science with the transformation of care and a joint agreement between all partners on priorities and needs are essential to ensure a better management of allergic diseases and asthma in the advent of precision medicine together with global access to innovative and affordable diagnostics and therapeutics. © 2019 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.